Assoc. Prof. CEMALİYE AKYERLİ BOYLU

Publication Network

Articles 31

1. Pathogenicity Prediction of Missense Variations in Hereditary Cancer Genes

AKYERLİ BOYLU C., Gerdan G., BÜLBÜL A. A., Keskin-Karakoyun H., Yuksel S. K., Timucin E.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.27, no.5, 2026 (SCI-Expanded, Scopus)

2. A Comprehensive Analysis of Novel Variations Associated with Bile Duct Cancer: Insights into Expression, Methylation, and 3D Protein Structure

BÜLBÜL A. A., Gerdan G., Portakal C., Bajrami S., AKYERLİ BOYLU C.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.26, no.23, 2025 (SCI-Expanded, Scopus) Sustainable Development

3. Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker Study

Manto K., Ustun Yilmaz S., PALA KARA Z., KARA H., TOKAT F., AKYERLİ BOYLU C., et al.

DISEASES , vol.13, no.6, 2025 (ESCI, Scopus) Sustainable Development

4. Mitochondria and Cancer

Gerdan G., YÜKSEL KILIÇTURGAY Ş., AKYERLİ BOYLU C.

Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi , vol.32, no.1, pp.95-106, 2025 (TRDizin)

5. Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer

Karakoyun H. K., Yuksel S. K., Amanoglu I., Naserikhojasteh L., Yesilyurt A., Yakicier C., et al.

FRONTIERS IN GENETICS , vol.14, 2023 (SCI-Expanded, Scopus)

6. Sensitive Detection of Molecular Targets in Cancer by Minisequencing

YÜKSEL KILIÇTURGAY Ş., AKYERLİ BOYLU C.

Acıbadem Sağlık Bilimleri Dergisi , vol.12, no.3, 2021 (TRDizin) Sustainable Development

7. Yeni Nesil Dizileme Teknolojileri İle Kanserde Mitokondriyal DNA Analizi

YÜKSEL KILIÇTURGAY Ş., AKYERLİ BOYLU C.

Harran Üniversitesi Tıp Fakültesi Dergisi , vol.18, no.1, pp.40-44, 2021 (TRDizin)

8. Sequential filtering for clinically relevant variants as a method for clinical interpretation of whole exome sequencing findings in glioma

Ülgen E., Can Ö., Bilguvar K., Akyerli Boylu C., Kılıçturgay Yüksel Ş., Erşen Danyeli A., et al.

BMC MEDICAL GENOMICS , vol.14, no.1, 2021 (SCI-Expanded, Scopus)

9. Analysis of Mitochondrial DNA Control Region D-Loop in Gliomas: Result of 52 Patients

Yuksel S. K., ÖZDUMAN K., Yilmaz E., PAMİR AKSOY N. A., AKYERLİ BOYLU C.

Turkish Neurosurgery , vol.31, no.3, pp.368-372, 2021 (SCI-Expanded, Scopus)

10. Mutations and Copy Number Alterations in IDH Wild-Type Glioblastomas Are Shaped by Different Oncogenic Mechanisms

Ulgen E., Karacan S., Gerlevik U., CAN Ö., Bilguvar K., OKTAY Y., et al.

BIOMEDICINES , vol.8, no.12, 2020 (SCI-Expanded, Scopus)

11. Mutations and copy number alterations in diffuse gliomas are shaped by different mechanisms

ÖZDUMAN K., Ulgen E., Karacan S., Gerlevik U., CAN Ö., Bilguvar K., et al.

European Journal of Cancer , vol.138, 2020 (SCI-Expanded, Scopus)

12. Lack of hotspot mutations other than TP53 R249S in aflatoxin B1 associated hepatocellular carcinoma

AKYERLİ BOYLU C., YÜKSEL KILIÇTURGAY Ş., Yakicier M. C.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.45, no.4, pp.451-453, 2020 (SCI-Expanded, Scopus, TRDizin)

13. Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas

Ulgen E., CAN Ö., Bilguvar K., OKTAY Y., AKYERLİ BOYLU C., Danyeli A., et al.

JOURNAL OF NEUROSURGERY , vol.132, no.5, pp.1435-1446, 2020 (SCI-Expanded, Scopus)

14. Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor

Dalva-Aydemir S., AKYERLİ BOYLU C., Yuksel S. K., Keskin H., Yakicier M. C.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , vol.23, no.10, pp.486-495, 2019 (SCI-Expanded, Scopus) Sustainable Development

15. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas

AKYERLİ BOYLU C., Yuksel S., CAN Ö., Erson-Omay E. Z., OKTAY Y., Cosgun E., et al.

JOURNAL OF NEUROSURGERY , vol.128, no.4, pp.1102-1114, 2018 (SCI-Expanded, Scopus)

16. Angiogenesis, Invasion, and Metastasis Characteristics of Hepatocellular Carcinoma

Yuksel Ş., Akyerli C., YAKICIER M. C.

JOURNAL OF GASTROINTESTINAL CANCER , vol.48, no.3, pp.256-259, 2017 (Peer-Reviewed Journal)

17. Gliom Gelişiminde Genetik Yatkınlığın Rolü

OKTAY Y., AKYERLİ BOYLU C., ÖZDUMAN K.

Türk Nöroşirürji dergisi , vol.27, no.2, pp.122-130, 2017 (Peer-Reviewed Journal)

18. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation

OKTAY Y., Ulgen E., CAN Ö., AKYERLİ BOYLU C., Yuksel S., Erdemgil Y., et al.

SCIENTIFIC REPORTS , vol.6, 2016 (SCI-Expanded, Scopus)

19. Gliomların Patolojisi ve Moleküler Biyolojik Özellikleri

OKTAY Y., AKYERLİ BOYLU C., YAKICIER M. C., ÖZDUMAN K., SAV M. A.

Urologic Clinics Of North America , vol.2, no.3, pp.17-22, 2014 (SCI-Expanded, Scopus)

20. Y Oktay, C Boylu Akyerli, MC Yakıcıer, K Özduman, MA Sav. Gliomların Patolojisi ve Moleküler Biyolojik Özellikleri

Akyerli Boylu C.

Türkiye Kanser Gündemi , vol.2, no.3, pp.17-22, 2014 (Peer-Reviewed Journal)

21. C Boylu Akyerli, Y Oktay, MC Yakıcıer, Ö Can, K Özduman. Gliomların Moleküler Patogenezi

Akyerli Boylu C.

Türkiye Kanser Gündemi , vol.2, no.3, pp.23-27, 2014 (Peer-Reviewed Journal)

22. Gliomların Moleküler Patogenezi

AKYERLİ BOYLU C., OKTAY Y., CAN Ö., YAKICIER M. C., ÖZDUMAN K.

Urologic Clinics Of North America , vol.2, no.3, pp.23-27, 2014 (SCI-Expanded, Scopus)

23. The SOCS-1 gene methylation in chronic myeloid leukemia patients

Hatirnaz M., Ure U., Ar C., Akyerli C., Soysal T., Ferhanoglu B., et al.

American Journal of Hematology , vol.82, no.8, pp.729-730, 2007 (SCI-Expanded, Scopus)

24. Endothelial progenitor cells display clonal restriction in multiple myeloma

Braunstein M., Oezcelik T., Bagislar S., Vakil V., Smith E. L. P., Dai K., et al.

BMC CANCER , vol.6, 2006 (SCI-Expanded, Scopus)

25. Expression of IFITM1 in chronic myeloid leukemia patients

AKYERLİ BOYLU C., BEKSAÇ M., Holko M., Frevel M., Dalva K., ÖZBEK U., et al.

Leukemia Research , vol.29, no.3, pp.283-286, 2005 (SCI-Expanded, Scopus)

26. Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer

Sevinc A., Yannoukakos D., Konstantopoulou I., Manguoglu E., Luleci G., Colak T., et al.

ANTICANCER RESEARCH , vol.24, no.4, pp.2547-2549, 2004 (SCI-Expanded, Scopus) Sustainable Development

27. Analysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemias

Akyerli C., Ozbek U., Aydin-Sayitoglu M., Sirma S., Ozcelik T.

Journal of Cancer Research and Clinical Oncology , vol.129, no.10, pp.604-605, 2003 (SCI-Expanded, Scopus)

28. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy

Topcu M., AKYERLİ BOYLU C., Sayi A., Toruner G., Kocoglu S., Cimbis M., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.10, no.1, pp.77-81, 2002 (SCI-Expanded, Scopus)

29. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population

Toruner G., Akyerli C., Ucar A., Aki T., Atsu N., Ozen H., et al.

ARCHIVES OF TOXICOLOGY , vol.75, no.8, pp.459-464, 2001 (SCI-Expanded, Scopus) Sustainable Development

30. Frequent demonstration of human herpesvirus 8 (HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM)

Beksac M., Ma M., Akyerli C., DerDanielian M., Zhang L., Liu J., et al.

LEUKEMIA , vol.15, no.8, pp.1268-1273, 2001 (SCI-Expanded, Scopus)

31. Survey of factor V Leiden and prothrombin gene mutations in systemic lupus erythematosus

Topaloglu R., Akierli C., Bakkaloglu A., Aydintug O., Ozen S., Besbas N., et al.

CLINICAL RHEUMATOLOGY , vol.20, no.4, pp.259-261, 2001 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 44

1. Nesfatin-1 Have Role in The Action Mechanism of Cholinergic Anti-inflammatory Pathway in the Gastrointestinal Tract

KOLGAZİ M., Çilingir S., AKYERLİ BOYLU C.

IUPS, Frankfurt, Germany, 11 - 14 September 2025, (Summary Text)

2. Regulatory Variations in Oligodendrogliomas: A Targeted Approach to 1p and 19q Genomic Alterations

Gerdan G., YÜKSEL KILIÇTURGAY Ş., OKTAY Y., ERŞEN DANYELİ A., PAMİR M. N., ÖZDUMAN K., et al.

X. Multidisciplinary Cancer Research Congress., Eskişehir, Turkey, 08 May 2025, (Summary Text)

3. Mutations and copy number alterations in diffuse gliomas are shaped by different mechanisms

ÖZDUMAN K., Ulgen E., Karacan S., Gerlevik U., CAN Ö., Bilguvar K., et al.

32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, ELECTR NETWORK, 24 - 25 October 2020, (Summary Text)

4. Lower-Grade Gliomas With Molecular Features Of Glioblastoma Have Distinct Tumor Characteristics and Better Survival Than WHO-Grade IV Counterparts.

Özduman K., Erşen Danyeli A., Akyerli Boylu C., Pamir M. N.

AANS 2020 , Massachusetts, United States Of America, 25 - 29 April 2020, vol.1, no.1, pp.1, (Summary Text)

5. IDH-Mutant Gliomas Differ in Distribution of Mitochondrial Genomic Alterations

Ozduman K., Yuksel Ş., Akyerli C., Bilguvar K., Ersen-Danyeli A., Yilmaz E., et al.

Annual Scientific Meeting of the American-Association-of-Neurological-Surgeons (AANS), Massachusetts, United States Of America, 25 - 29 April 2020, pp.84, (Summary Text)

6. IS THE PATHOLOGICAL-GRADE RELEVANT IN "IDH-WILD TYPE, TERT-MUTANT" DIFFUSE-GLIOMAS? AN ANALYSIS IN 147 PATIENTS

Danyeli A., Akyerli C., DİNÇER A., Cosgun E., Abacioglu U., PAMİR M. N., et al.

14th Meeting of the European-Association-of-Neuro-Oncology (EANO), Lyon, France, 19 - 22 September 2019, vol.21, pp.90, (Summary Text)

7. Chromatin Modifier Alterations Are Very Common But Mostly Random in Diffuse Gliomas

Özduman K., Can Ö., Erşen Danyeli A., Akyerli Boylu C., Pamir M. N.

AANS, California, United States Of America, 13 - 17 April 2019, pp.1, (Summary Text)

8. Orexin peptides have role in the action mechanism of cholinergic anti-inflammatory pathway in the gastrointestinal tract

Kolgazi Gürcanlı M., Çilingir S., Kılınç E., Akyerli Boylu C.

Union of thrace universities 2nd international health sciences congress, Tekirdağ, Turkey, 15 - 17 November 2018, (Unpublished)

9. Analysis of mutational processes in 23 adult hemispheric diffuse gliomas identifies DNA-damage repair deficiency as a major contributor to gliomagenesis

Ozduman K., Ulgen E., Can Ö., Akyerli C., Pamir M. N.

Annual Scientific Meeting of the American-Association-of-Neurologic-Surgeons (AANS), Louisiana, United States Of America, 29 April - 02 May 2018, vol.128, pp.11, (Summary Text)

10. Surgical Outcome of Adult Hemispheric Glioblastoma is Determined by the Molecular-Subset: An Analysis of 142 Patients.

Ozduman K., Akyerli C., Yapicier O., Cosgun E., Yakicier M. C., Yuksel Ş., et al.

Annual Scientific Meeting of the American-Association-of-Neurological-Surgeons (AANS), Los-Angeles, Chile, 22 - 26 April 2017, vol.126, (Summary Text)

11. An analysis for the role of telomerase hTERT promoter mutations in gliomagenesis

ÖZDUMAN K., AKYERLİ BOYLU C., YÜKSEL Ş., CAN Ö., OKTAY Y., Nanni P., et al.

82nd Annual Scientific Meeting of the American-Association-of-Neurological-Surgeons, San Francisco-California, United States Of America, 5 - 09 April 2014, vol.122, pp.1563-1564, (Summary Text)

12. An analysis for the role of telomerase (hTERT) promoter mutations in gliomagenesis

Ozduman K., Akyerli C., Yuksel Ş., Can Ö., Oktay Y., Nanni P., et al.

83rd Annual Scientific Meeting of the American-Association-of-Neurological-Surgeons, San-Francisco, Costa Rica, 5 - 09 April 2014, vol.122, (Summary Text)

13. Increased risk of gliomas in rs55705857 risk-allele carriers may be explained by immune mechanisms

OKTAY Y., ülgen e., CAN Ö., AKYERLİ BOYLU C., YÜKSEL Ş., YAKICIER M. C., et al.

83rd American Association of Neurological Surgeons Annual Scientific Meeting, United States Of America, 2 - 06 May 2015, (Summary Text)

14. A clinically relevant IDH and TERTp mutation based classification scheme for diffuse gliomas

Özduman K., Akyerli Boylu C., Yüksel Kılıçturgay Ş., Can Ö., Coşgun E., Ulgen E., et al.

AANS/CNS Section on Tumors 11th Biennial Satellite Symposium, Washington, United States Of America, 01 May 2015, (Summary Text)

15. Tumor biomarker research in neuroscience: Application to brain tumors.

Can Ö., Akyerli Boylu C., Yüksel Kılıçturgay Ş., Oktay Y., Özpınar A., Nanni P., et al.

International Workshop on MS-Based Proteomics Bioinformatics and Health Informatics, İzmir, Turkey, 14 - 16 May 2014, (Summary Text)

16. Özge Can, Cemaliye Akyerli, Şirin Yüksel, Yavuz Oktay, Paolo Nanni, Nathalie Selevsek, Jonas Grossmann, Aysel Özpınar, Aydın Sav, Cengiz Yakıcıer, M Necmettin Pamir, Koray Özduman (2014) Tumor biomarker research in neuroscience: Application to brain tumors.

Can Ö., Akyerli Boylu C., Yüksel Kılıçturgay Ş., Oktay Y., Özpınar A., Yakıcıer M. C., et al.

International Workshop on MS-Based Proteomics Bioinformatics and Health Informatics,, İzmir, Turkey, 14 - 16 May 2014, pp.1, (Summary Text)

17. Proteomic correlation of telomerase mutations in gliomas

Akyerli Boylu C., Yüksel Kılıçturgay Ş., Can Ö., Oktay Y., Özpınar A., Yakıcıer M. C., et al.

65th Annual Meeting of the German Society of Neurosurgery, Dresden, Germany, 11 - 14 May 2014, pp.1, (Summary Text)

18. Analysis of the effect of 1p/19q co-deletions in WHO grade-II oligodendrogliomas

Can Ö., Yüksel Kılıçturgay Ş., Oktay Y., Akyerli Boylu C., Özpınar A., Yakıcıer M. C., et al.

65th Annual Meeting of the German Society of Neurosurgery, Dresden, Germany, 11 - 14 May 2014, pp.1, (Summary Text)

19. Do oncogenic changes differ according to anatomic localization in low- grade gliomas?

Can Ö., Oktay Y., Akyerli Boylu C., Yüksel Kılıçturgay Ş., Yakıcıer M. C., Pamir M. N., et al.

American Association of Neurological Surgeons (AANS) 82nd Annual Scientific Meeting,, California, United States Of America, 5 - 09 April 2014, pp.1, (Summary Text)

20. Oncogenic changes beyond the intraoperative-MRI determined T2-hyperintense tumor border in gliomas

Akyerli Boylu C., Yüksel Kılıçturgay Ş., Can Ö., Oktay Y., Yakıcıer M. C., Pamir M. N., et al.

American Association of Neurological Surgeons (AANS) 82nd Annual Scientific Meeting, California, United States Of America, 5 - 09 April 2014, pp.1, (Summary Text)

21. Correlation of hTERT promoter mutations in gliomas with other major oncogenic changes

Özduman K., Akyerli Boylu C., Yüksel Kılıçturgay Ş., Can Ö., Oktay Y., Yakıcıer M. C., et al.

American Association of Neurological Surgeons (AANS) 82nd Annual Scientific Meeting , California, United States Of America, 5 - 09 April 2014, pp.1, (Summary Text)

22. Analysis of molecular mechanisms attributable to glioma predisposition caused by rs55705857 at 8q24.21

Oktay Y., Yüksel Kılıçturgay Ş., Akyerli Boylu C., Can Ö., Pamir M. N., Özduman K.

6th Evidence Based Multidiscipliniary Neurooncology Symposium, İstanbul, Turkey, 2 - 03 November 2013, pp.1, (Summary Text)

23. Analysis of hTERT promoter mutations in gliomas

Akyerli Boylu C., Yüksel Kılıçturgay Ş., Can Ö., Oktay Y., Pamir M. N., Özduman K.

6th Evidence Based Multidiscipliniary Neurooncology Symposium, İstanbul, Turkey, 2 - 03 November 2013, pp.1, (Summary Text)

24. Polymorphism at 8q24 21 is associated with increased risk for low grade gliomas in the Turkish Population

OKTAY Y., AKYERLİ BOYLU C., FINDIK S., YÜKSEL KILIÇTURGAY Ş., MUTLU A., Ulgen E., et al.

Gordon Research Conference “Cancer Genetics and Epigenetics”, Italya Lucca (Barga), Italy, 21 - 26 April 2013, (Summary Text)

25. Analysis of genetic variations caused by environmental factor aflatoxin in hepatocellular carcinoma

Akyerli Boylu C., Acun T., Yakıcıer M. C.

9th National Medical Genetics Congress of Turkish Medical Genetics Society with International Participation, Clinical Genetics, 78: 74 , İstanbul, Turkey, 1 - 05 December 2010, vol.78, pp.74, (Summary Text)

26. Linc RNA expression in hepatocellular carcinoma

AĞIRBAŞLI D., AKYERLİ BOYLU C., ACUN T., Keller A., YAKICIER M. C.

9th National Medical Genetics Congress of Turkish Medical Genetics Society with International Participation, İstanbul, Turkey, 01 December 2010, (Summary Text)

27. Türk populasyonundaki miyeloproliferatif hastalıklarda JAK2 V617F mutasyon analizi

AKYERLİ BOYLU C., Taşbasan B., GÜÇ D., KANSU E.

Ulusal Kanser Kongresi, Antalya., Antalya, Turkey, 19 - 23 April 2007, (Summary Text)

28. Kanser Genomu ve Kliniğe Yansıması

AKYERLİ BOYLU C.

Onkoloji 2006, Hacettepe Üniversitesi Onkoloji Enstitüsü, Ankara, Turkey, 23 - 25 November 2006, pp.87-93, (Full Text) Sustainable Development

29. Mikroarrays in Cancer

AKYERLİ BOYLU C.

European School of Genetics, 9th course in Cancer Genetics, Bertinoro di Romagna, Italy., 1 - 05 October 2005 Sustainable Development

30. Hematoloji'de Mikroarray Kullanımı

AKYERLİ BOYLU C.

Türk Hematoloji Derneği, Temel Moleküler Hematoloji Kursu, Moleküler Hematoloji ve Sitogenetik Alt Komitesi, Mersin, Turkey, 12 - 13 March 2005, pp.23-24, (Full Text)

31. Evidence for clonality in circulating endothelial progenitor cells in multiple myeloma.

Ozcelik T., Vakil V., Smith E., Braunstein M., Maroney J., Klueppelberg U., et al.

46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America, 4 - 07 December 2004, vol.104, (Summary Text)

32. Disturbed X-chromosome inactivation mosaicism in females with scleroderma

Ozbalkan Z., Bagislar S., Kiraz S., AKYERLİ BOYLU C., Ozer H., Birlik A., et al.

68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Antonio, Northern Mariana Islands, 16 - 21 October 2004, vol.50, (Summary Text)